no ME recurrence group | ME recurrence group | p1-value* (between A and C) | p2-value* (between B and D) | |||||
---|---|---|---|---|---|---|---|---|
A:major BRVO (n = 10) | B:macular BRVO (n = 11) | p-value* | C:major BRVO (n = 12) | D: macular BRVO (n = 11) | p-value* | |||
Superficial capillary plexus | ||||||||
Mean FAZ area (mm2) | 0.40 ± 0.10 | 0.39 ± 0.11 | 0.484 | 0.50 ± 0.14 | 0.56 ± 0.37 | 0.312 | 0.022 | 0.123 |
Mean extent of ring loss (°) | 21 | 13.5 | 0.274 | 72.5 | 66 | 0.472 | 0.078 | 0.007 |
Macular VD | 78.21 ± 10.82 | 75.32 ± 7.39 | 0.960 | 77.22 ± 7.62 | 79.08 ± 7.98 | 0.264 | 0.334 | 0.154 |
Hemi-VD disparity | 8.91 ± 12.55 | 9.81 ± 9.28 | 0.189 | 14.41 ± 10.72 | 11.47 ± 5.95 | 0.409 | 0.022 | 0.171 |
Deep capillary plexus | ||||||||
Mean FAZ area (mm2) | 0.47 ± 0.16 | 0.49 ± 0.11 | 0.374 | 0.55 ± 0.14 | 0.68 ± 0.37 | 0.245 | 0.098 | 0.049 |
Mean extent of ring loss (°) | 15 | 43.5 | 0.097 | 85 | 90 | 0.448 | 0.006 | 0.015 |
Macular VD | 73.84 ± 8.21 | 73.59 ± 6.97 | 0.154 | 70.21 ± 6.35 | 73.87 ± 5.71 | 0.089 | 0.111 | 0.484 |
Hemi-VD disparity | 13.76 ± 13.22 | 14.42 ± 12.29 | 0.401 | 18.95 ± 10.31 | 25.06 ± 13.75 | 0.206 | 0.099 | 0.026 |